Isthmus Partners’s CVS Health CVS Stock Holding History

Isthmus Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-38	Closed	-$3K	–	283
2017 Q1	$3K	Hold	38	–	–	﹤0.01%	283
2016 Q4	$3K	Buy	+38	New	+$3.08K	﹤0.01%	292

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Isthmus Partners's CVS Position: Q2 2017 in Review

Isthmus Partners sold out of CVS Health (CVS) in Q2 2017, closing a stake of 38 shares — an estimated $3K sold.

Isthmus Partners first reported a position in CVS in Q4 2016 and held it in 2 quarters. The position peaked at $3K in Q1 2017. 1,552 funds tracked by Wall St. Rank hold CVS as of Q2 2017.

Isthmus Partners reported no remaining CVS Health position as of Q2 2017 after selling out during the quarter.
Isthmus Partners sold 38 CVS Health shares in Q2 2017, an estimated $3K.
Isthmus Partners first reported a position in CVS Health in Q4 2016 and held it in 2 quarters.
Isthmus Partners's CVS Health position peaked at $3K in Q1 2017.
1,552 funds tracked by Wall St. Rank held CVS Health as of Q2 2017.

Based on Isthmus Partners's 13F filing for Q2 2017, filed 11 Aug 2017.